IRIS
FAGONE, PAOLO FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.187
AS - Asia 2.334
EU - Europa 2.184
SA - Sud America 556
AF - Africa 518
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 11.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.028
SG - Singapore 1.040
IT - Italia 901
CN - Cina 860
BR - Brasile 511
IE - Irlanda 431
CI - Costa d'Avorio 303
UA - Ucraina 278
SN - Senegal 155
DE - Germania 147
RU - Federazione Russa 130
CA - Canada 123
VN - Vietnam 110
KR - Corea 104
GB - Regno Unito 60
SE - Svezia 55
IN - India 43
FI - Finlandia 35
MX - Messico 26
JP - Giappone 24
BD - Bangladesh 23
FR - Francia 22
IR - Iran 21
AR - Argentina 19
PL - Polonia 19
ZA - Sudafrica 18
BE - Belgio 17
NL - Olanda 16
IQ - Iraq 15
CH - Svizzera 13
HK - Hong Kong 13
UZ - Uzbekistan 13
EC - Ecuador 12
ES - Italia 10
NG - Nigeria 10
TR - Turchia 10
ID - Indonesia 9
AE - Emirati Arabi Uniti 7
AT - Austria 7
MA - Marocco 7
PK - Pakistan 7
BG - Bulgaria 6
GR - Grecia 6
KE - Kenya 6
LT - Lituania 6
EU - Europa 5
GE - Georgia 5
VE - Venezuela 5
AU - Australia 4
EG - Egitto 4
LB - Libano 4
MK - Macedonia 4
RO - Romania 4
SA - Arabia Saudita 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CO - Colombia 2
HU - Ungheria 2
KG - Kirghizistan 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 11.789
Salva come PNG Salva come JPEG
Città #
Dallas 1.931
Santa Clara 794
Singapore 550
Chandler 464
Dublin 430
Jacksonville 305
Abidjan 303
Chicago 284
Hefei 225
Catania 205
Houston 205
Boardman 202
Ashburn 192
Beijing 158
Dakar 155
Cambridge 117
Lawrence 117
Andover 112
Seoul 103
Nanjing 88
Civitanova Marche 83
Toronto 76
Los Angeles 71
Des Moines 65
San Mateo 51
Wilmington 48
Grafing 45
New York 44
São Paulo 42
Palermo 40
Dong Ket 36
Rome 34
Saint Petersburg 32
The Dalles 32
Columbus 31
Nanchang 29
Lappeenranta 27
Ottawa 27
Munich 26
Jiaxing 24
Hebei 23
Ho Chi Minh City 23
Nizza di Sicilia 23
Council Bluffs 22
Tokyo 22
Vercelli 21
Hanoi 20
Rio de Janeiro 20
Brooklyn 19
Washington 19
Bremen 18
Messina 18
Sant'Antonio Abate 18
Tianjin 18
Brussels 17
Acireale 16
Boston 16
San Francisco 16
Augusta 15
Changsha 15
Denver 15
Milan 15
Moscow 15
Johannesburg 14
London 13
Shenyang 13
Ardabil 12
Hong Kong 12
Leawood 12
Warsaw 12
Abuja 10
Amsterdam 10
Atlanta 10
Bronte 10
Dearborn 10
Guangzhou 10
Phoenix 10
Belo Horizonte 9
Campinas 9
Licata 9
Padova 9
Stockholm 9
Curitiba 8
Mascalucia 8
Mexico City 8
Montreal 8
Paris 8
Ragusa 8
Baghdad 7
Chennai 7
Chiaramonte Gulfi 7
Dhaka 7
Hangzhou 7
Monmouth Junction 7
Motta Sant'Anastasia 7
Norwalk 7
Porto Alegre 7
Pozzallo 7
Redondo Beach 7
Seattle 7
Totale 8.562
Salva come PNG Salva come JPEG
Nome #
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 248
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 202
Advances in targeting signal transduction pathways. 190
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 173
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 169
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 165
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 147
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 146
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 140
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 139
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 133
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 128
Characterization of the pathophysiological role of CD47 in uveal melanoma 127
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 126
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 123
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 123
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 119
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 118
Emerging therapeutic targets for the treatment of hepatic fibrosis 118
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 118
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 118
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 117
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 114
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 114
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 113
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 112
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 111
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 110
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 110
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 110
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 107
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 107
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 105
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 104
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 104
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 103
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 103
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 102
mTOR as a multifunctional therapeutic target in HIV infection 102
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 102
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 99
Modulation of heat shock proteins during macrophage differentiation. 98
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 97
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 94
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 91
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 91
). NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?. 88
Cathepsin A levels in CD4+ T cells from HIV-positive patients 86
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 82
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 82
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology 80
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 80
Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells. 80
Meta-analysis of transcriptomic data of dorsolateral prefrontal cortex and of peripheral blood mononuclear cells identifies altered pathways in Schizophrenia 80
Therapeutic potential of carbon monoxide in multiple sclerosis 79
Immunoexpression and localization of heme-oxygenase-1 and MIF in lung exposed to asbestos-like fibers: an in vivo study 79
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 79
In silico and in vivo analysis of IL37 in multiple sclerosis reveals its probable homeostatic role on the clinical activity, disability, and treatment with fingolimod 77
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 75
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 75
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 75
Comprehensive analysis of rna-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder 75
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 74
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 74
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 74
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 74
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 73
The immunobiology of apotransferrin in type 1 diabetes 73
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 73
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 73
The cytokine network in the pathogenesis of major depressive disorder. Close to translation? 73
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 72
Role of NGAL (Lcn2) in prostate cancer invasion 72
Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma 72
The role of macrophage migration inhibitory factor in Alzheimer′s disease: Conventionally pathogenetic or unconventionally protective? 72
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 72
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 70
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 70
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 70
Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue 70
The effect of omega-3 fatty acids on capsular tissue around the breast implants 70
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 70
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy 69
Immune modifying capacity of new melanoma therapeutics with the potency to increase efficacy of Adoptive T-cell Therapy – potential synergism of combinations 69
Naturally occurring compounds in differentiation based therapy of cancer. 69
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL 68
Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis 68
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis 67
Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-β secretion by antigen-specific CD8 T cells 67
Expression of DNA methylation genes in secondary progressive multiple sclerosis 67
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 67
New melanoma therapeutics to improve adoptive T cell therapy - potential synergism of combinations 66
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 66
Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression 66
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 65
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 65
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 64
Th17 common genes in CD4 T-cells of HIV-1-infected naïve patients and elite controllers 64
HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? 64
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 64
Totale 9.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021533 0 0 0 0 162 16 66 5 84 5 144 51
2021/2022865 76 119 4 19 143 21 126 33 65 3 20 236
2022/20231.587 124 82 29 127 145 246 18 347 350 27 48 44
2023/2024793 47 105 46 60 37 243 8 44 4 23 90 86
2024/20253.288 40 502 200 149 774 326 152 111 243 283 295 213
2025/20263.789 497 1.335 1.222 484 251 0 0 0 0 0 0 0
Totale 12.031